Home/ Stocks/ CYCN

Cyclerion Therapeutics, Inc. Common Stock

CYCN XNAS

$5.84 +4.29 (+276.77%) ▲ 15-min delayed

Open

$5.42

High

$8.48

Low

$5.37

Volume

234.66M

Market Cap

$5.90M

About Cyclerion Therapeutics, Inc. Common Stock

Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 1 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q3 2025	$875.0K	$-976,000	$-0.30
Q2 2025	$93.0K	$-324,000	$-0.11
Q1 2025	$81.0K	$-1,429,000	$-0.56
FY 2024	$2.00M	$-3,057,000	$-1.21

TickerDaily Coverage

Why Is Cyclerion Therapeutics, Inc. Common Stock (CYCN) Stock Up 320.3% Today?

Market News Alex Chen · 16 min ago

Cyclerion Therapeutics (CYCN) exploded higher Wednesday, gaining 320.3% to $6.49 on unprecedented...

Why Is Cyclerion Therapeutics, Inc. Common Stock (CYCN) Stock Up 253.5% Today?

Penny Stocks Marcus Rivera · 4h ago

Cyclerion Therapeutics (CYCN) exploded 253.5% Wednesday, April 1, 2026, closing at $5.43 after...

View All Coverage →

Get CYCN Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Cyclerion Therapeutics, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.